Akut Solunum Sıkıntısı Sendromu
Synopsis
Acute respiratory distress syndrome (ARDS) is a form of non-cardiogenic pulmonary edema leading to hypoxemia and dyspnea due to alveolar damage secondary to an inflammatory process of pulmonary or systemic origin. Following its initial description by Ashbaugh in 1967, diagnostic criteria were updated through the AECC, the 2012 Berlin definition, and the Kigali modification developed for resource-limited settings. Accounting for 10.4% of intensive care unit admissions, ARDS carries an overall hospital mortality rate of 40%. While pneumonia, aspiration, and extrapulmonary sepsis are the most common etiological factors, genetic susceptibility and mechanical ventilation also contribute to its development. Pathophysiologically, increased endothelial and epithelial permeability leads to the accumulation of protein-rich edema fluid in the alveolar space, progressing through exudative, proliferative, and fibrotic phases. Diagnosis relies on clinical symptoms alongside chest radiography, computed tomography, microbiological cultures, and evaluation of differential diagnoses. The cornerstone of treatment is supportive care, with lung-protective mechanical ventilation utilizing a low tidal volume of 6 mL/kg and plateau pressure maintained below 30 cmH2O serving as the gold standard. Although PEEP, prone positioning for at least 12 hours in moderate-to-severe cases, early neuromuscular blockade, and ECMO in severe cases provide clinical benefits, routine administration of surfactant, statins, or glucocorticoids has shown no positive effect on mortality.
References
Ashbaugh D, Bigelow DB, Petty T, et al. Acute respiratory distress in adults. The Lancet. 1967;290(7511):319-23.
Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-24.
Force ADT, Ranieri V, Rubenfeld G, et al. Acute respiratory distress syndrome. Jama. 2012;307(23):2526-33.
Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition. American journal of respiratory and critical care medicine. 2016;193(1):52-9.
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. Jama. 2016;315(8):788-800.
Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Current opinion in critical care. 2016;22(1):1-6.
Rezoagli E, Fumagalli R, Bellani G. Definition and epidemiology of acute respiratory distress syndrome. Annals of translational medicine. 2017;5(14).
Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nature reviews Disease primers. 2019;5(1):1-22.
Meyer NJ, Christie JD, editors. Genetic heterogeneity and risk of acute respiratory distress syndrome. Seminars in respiratory and critical care medicine; 2013: Thieme Medical Publishers.
Mac Sweeney R, McAuley DF. Acute respiratory distress syndrome. The Lancet. 2016;388(10058):2416-30.
Huppert LA, Matthay MA, Ware LB. Pathogenesis of acute respiratory distress syndrome. Seminars in respiratory and critical care medicine; 2019: NIH Public Access.
Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. New England Journal of Medicine. 2017;377(6):562-72.
Saguil A, Fargo MV. Acute respiratory distress syndrome: diagnosis and management. American family physician. 2020;101(12):730-8.
García-Laorden MI, Lorente JA, Flores C, et al. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017;5(14):283.
Sheard S, Rao P, Devaraj A. Imaging of acute respiratory distress syndrome. Respiratory care. 2012;57(4):607-12.
Gattinoni L, Caironi P, Pelosi P, et al. What has computed tomography taught us about the acute respiratory distress syndrome? American journal of respiratory and critical care medicine. 2001;164(9):1701-11.
Bellani G, Laffey JG, Pham T, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. American journal of respiratory and critical care medicine. 2017;195(1):67-77.
Frat J-P, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New England Journal of Medicine. 2015;372(23):2185-96.
The A. Network Ventilation with lower tidal volumes as compar ed with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-8.
Papazian L, Aubron C, Brochard L, et al. Formal guidelines: management of acute respiratory distress syndrome. Annals of intensive care. 2019;9(1):69.
Siegel MD, Hyzy RC. Ventilator management strategies for adults with acute respiratory distress syndrome. Wolters Kluwer; 2021.
Martínez Ó, Nin N, Esteban A. Prone position for the treatment of acute respiratory distress syndrome: a review of current literature. Archivos de Bronconeumología ((English Edition)). 2009;45(6):291-6.
Munshi L, Del Sorbo L, Adhikari NK, et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Annals of the American Thoracic Society. 2017;14(Supplement 4):S280-S8.
Ferguson ND, Cook DJ, Guyatt GH, et al. High-frequency oscillation in early acute respiratory distress syndrome. New England Journal of Medicine. 2013;368(9):795-805.
Young D, Lamb SE, Shah S, et al. High-frequency oscillation for acute respiratory distress syndrome. New England Journal of Medicine. 2013;368(9):806-13.
Papazian L, Forel J-M, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. New England Journal of Medicine. 2010;363(12):1107-16.
Spieth P, Güldner A, de Abreu MG. Akutes Lungenversagen. Der Anaesthesist. 2017;66(7):539-52.
Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. New England Journal of Medicine. 2005;353(25):2683-95.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New England Journal of Medicine 354.16 (2006): 1671-1684.
Baudouin SV. Surfactant medication for acute respiratory distress syndrome. Thorax. 1997;52(Suppl 3):S9.
Xiong B, Wang C, Tan J, et al. Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Respirology. 2016;21(6):1026-33.
Cutts S, Talboys R, Paspula C, et al. Adult respiratory distress syndrome. The Annals of The Royal College of Surgeons of England. 2017;99(1):12-6.